NOVOCART®3D for Treatment of Articular Cartilage of the Knee

NCT01957722 ↗

Phase 3 Active not recruiting 233 enrolled Aesculap Biologics, LLC

RandomizedSingle-groupSingle-blindTreatment

Summary

This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.

Timeline

Start: 2013-12
Primary completion: 2025-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NOVOCART 3D	Cell therapy	—	—

Indications

No indication recorded.